Radicle Revive™ 24: A Randomized, Double-Blind, Placebo-Controlled, Direct-to-Consumer Trial Assessing the Impact of Health and Wellness Products on Hormonal Health and Associated Health Outcomes in Women With Menopausal Health Issues

Eligibility Criteria

• * Adults, 21 years of age and older at the time of electronic consent, inclusive of all ethnicities, races, genders and/or gender identities
• * Resides in the United States
• * Endorses less pain as a primary desire
• * Selects pain and/or looking to improve their pain as a reason for their interest in taking a health and wellness product
• * Expresses a willingness to take a study product and not know the product identity (active or placebo) until the end of the study
• * reports being pregnant, trying to become pregnant, or breastfeeding
• * Unable to provide a valid US shipping address and mobile phone number
• * The calculated validated health survey (PRO) score during enrollment represents less than mild severity
• * Reports a diagnosis of liver or kidney disease
• * Reports being a heavy drinker (defined as drinking 3 or more alcoholic beverages per day)
• * Unable to read and understand English
• * Reports current enrollment in a clinical trial
• * Lack of reliable daily access to the internet
• * Reports current or recent (within 3 months) use of chemotherapy or immunotherapy
• * Reports taking medications with a known moderate or severe interaction with any of the active ingredients studied, or a substantial safety risk: Anticoagulants, a medication that warns against grapefruit consumption, corticosteroids at doses greater than 5 mgs per day, oral anti-infectives (antibiotics, antifungals, antivirals) to treat an acute infection, antipsychotics, or MAO